Entecavir results in a rapid reduction in viral load in chronic hepatitis B patients who have failed lamivudine therapy: a randomized, placebo-controlled study in China
单位：[1]Shanghai Jing An Cent Hosp, Div Gastroenterol & Hepatol, Shanghai, 06492, Peoples R China[2]Shanghai 2 Med Univ, Rui Jin Hosp, Shanghai, Peoples R China[3]Capital Med Univ, Beijing Friendship Hosp, Beijing, Peoples R China首都医科大学附属北京友谊医院[4]Capital Med Univ, Beijing Di Tan HospHosp, Beijing, Peoples R China[5]Chongqing Med Univ, Hosp 2, Chongqing, Peoples R China[6]Bristol Myers Squibb Co, Shanghai, Peoples R China[7]Bristol Myers Squibb Co, Pharmaceut Res Inst, Wallingford, CT USA
Yao G.,Zhou X.,Xu D.,et al.Entecavir results in a rapid reduction in viral load in chronic hepatitis B patients who have failed lamivudine therapy: a randomized, placebo-controlled study in China[J].JOURNAL of CLINICAL VIROLOGY.2006,36:S88-S88.doi:10.1016/S1386-6532(06)80272-6.
APA：
Yao, G.,Zhou, X.,Xu, D.,Wang, B.,Ren, H....&MacDonald, L..(2006).Entecavir results in a rapid reduction in viral load in chronic hepatitis B patients who have failed lamivudine therapy: a randomized, placebo-controlled study in China.JOURNAL of CLINICAL VIROLOGY,36,
MLA：
Yao, G.,et al."Entecavir results in a rapid reduction in viral load in chronic hepatitis B patients who have failed lamivudine therapy: a randomized, placebo-controlled study in China".JOURNAL of CLINICAL VIROLOGY 36.(2006):S88-S88
